Safety and Feasibility of Using a Single Transradial Guiding Catheter for Primary PCI (NCT01759043) | Clinical Trial Compass
CompletedNot Applicable
Safety and Feasibility of Using a Single Transradial Guiding Catheter for Primary PCI
China360 participantsStarted 2012-12
Plain-language summary
The Rapid Trial is a randomized-controlled trial proposed to test the hypothesis that using a single guiding catheter for left and right coronary angiography and intervention in patients with ST elevation myocardial infarction (STEMI) can reduce procedure time, fluoroscopy time and Cath Lab door to balloon(C2B) time when compared with traditional approach which first underwent coronary angiography with diagnostic catheter followed by guiding catheter selection for intervention.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient must be \> 18 years of age.
* Patients have typical chest pain for at least 20 minutes and have ECG changes typical for STEMI (ST elevationā„2mm in two continuous precordial leads or ST elevationsā„1mm in two limb leads or new left bundle branch block) or ECG changes compatible with true posterior MI.
* Symptoms ā„ 30 min and ā¤12 hours
* Patient and treating interventional cardiologist agree for randomization.
* Patient provides written informed consent.
* Diagnostic and therapeutic intervention performed through trans-radial/ulnar artery approach.
* Palpable radial or ulnar artery
* Previous experience of the operator with at least 100 cases of radial artery access within the past year
Exclusion Criteria:
* Concurrent participation in other investigational study
* Current platelet count \<100 x 10\^9cells/L or Hgb \<10 g/dL.
* Absence of radial or ulnar artery pulsation
* Active bleeding or significant increased risk of bleeding, severe hepatic insufficiency, current peptic ulceration, proliferative diabetic retinopathy.
* Uncontrolled hypertension
* Prior CABG surgery
* Fibrinolytic therapy for current MI treatment
* patient have a life expectancy of \<180days